SCIE/SSCI/A&HCI收录期刊
|
|
| 按影响因子排序： 升 | 降 | 第44页 首页 上一页 下一页 末页 共有902条记录 |
| 序号 | JCR刊名缩写 | 期刊名称 | ISSN | 影响因子(2024) |
收录数据库 | JCR学科(分区) |
| 861 | EXPERT OPIN DRUG DIS | Expert Opinion on Drug Discovery | 17460441 | 4.9 | SCIE | PHARMACOLOGY & PHARMACY(Q1) |
| 862 | EXPERT OPIN DRUG MET | Expert Opinion on Drug Metabolism & Toxicology | 17425255 | 3.4 | SCIE | TOXICOLOGY(Q2) BIOCHEMISTRY & MOLECULAR BIOLOGY(Q2) PHARMACOLOGY & PHARMACY(Q2) |
| 863 | EXPERT OPIN DRUG SAF | Expert Opinion On Drug Safety | 14740338 | 3.1 | SCIE | PHARMACOLOGY & PHARMACY(Q2) |
| 864 | EXPERT OPIN EMERG DR | EXPERT OPINION ON EMERGING DRUGS | 14728214 | 2.7 | SCIE | PHARMACOLOGY & PHARMACY(Q2) |
| 865 | EXPERT OPIN INV DRUG | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 13543784 | 4.1 | SCIE | PHARMACOLOGY & PHARMACY(Q1) |
| 866 | EXPERT OPIN PHARMACO | EXPERT OPINION ON PHARMACOTHERAPY | 14656566 | 2.7 | SCIE | PHARMACOLOGY & PHARMACY(Q2) |
| 867 | EXPERT OPIN THER PAT | EXPERT OPINION ON THERAPEUTIC PATENTS | 13543776 | 4.6 | SCIE | CHEMISTRY, MEDICINAL(Q2) PHARMACOLOGY & PHARMACY(Q1) |
| 868 | EXPERT OPIN THER TAR | EXPERT OPINION ON THERAPEUTIC TARGETS | 14728222 | 4.4 | SCIE | PHARMACOLOGY & PHARMACY(Q1) |
| 869 | EXPERT REV ANTICANC | Expert Review of Anticancer Therapy | 14737140 | 2.8 | SCIE | ONCOLOGY(Q2) |
| 870 | EXPERT REV ANTI-INFE | Expert Review of Anti-Infective Therapy | 14787210 | 3.8 | SCIE | INFECTIOUS DISEASES(Q1) MICROBIOLOGY(Q2) PHARMACOLOGY & PHARMACY(Q2) |
| 871 | EXPERT REV CLIN IMMU | Expert Review of Clinical Immunology | 1744666X | 3.7 | SCIE | IMMUNOLOGY(Q2) |
| 872 | EXPERT REV CLIN PHAR | Expert Review of Clinical Pharmacology | 17512433 | 3 | SCIE | PHARMACOLOGY & PHARMACY(Q2) |
| 873 | EXPERT REV GASTROENT | Expert Review of Gastroenterology & Hepatology | 17474124 | 2.5 | SCIE | GASTROENTEROLOGY & HEPATOLOGY(Q2) |
| 874 | EXPERT REV HEMATOL | Expert Review of Hematology | 17474086 | 2.1 | SCIE | HEMATOLOGY(Q3) |
| 875 | EXPERT REV MED DEVIC | Expert Review of Medical Devices | 17434440 | 2.7 | SCIE | ENGINEERING, BIOMEDICAL(Q3) |
| 876 | EXPERT REV MOL DIAGN | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 14737159 | 3.6 | SCIE | PATHOLOGY(Q1) |
| 877 | EXPERT REV MOL MED | EXPERT REVIEWS IN MOLECULAR MEDICINE | 14623994 | 5.5 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY(Q1) MEDICINE, RESEARCH & EXPERIMENTAL(Q1) |
| 878 | EXPERT REV NEUROTHER | Expert Review of Neurotherapeutics | 14737175 | 3.4 | SCIE | CLINICAL NEUROLOGY(Q2) PHARMACOLOGY & PHARMACY(Q2) |
| 879 | EXPERT REV PHARM OUT | Expert Review of Pharmacoeconomics & Outcomes Research | 14737167 | 1.5 | SCIE | HEALTH CARE SCIENCES & SERVICES(Q3) PHARMACOLOGY & PHARMACY(Q4) |
| 880 | EXPERT REV PHARM OUT | Expert Review of Pharmacoeconomics & Outcomes Research | 14737167 | 1.5 | SSCI | HEALTH POLICY & SERVICES(Q4) |
| 按影响因子排序： 升 | 降 | 第44页 首页 上一页 下一页 末页 共有902条记录 |